Atopic dermatitis differential diagnosis: Difference between revisions

Jump to navigation Jump to search
Line 177: Line 177:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|-
|-
! Lichen simplex chronicus
! align="center" style="background:#DCDCDC;" |Lichen simplex chronicus
|
|
|
|
Line 206: Line 206:
|
|
|-
|-
! Ichthyosis vulgaris
! align="center" style="background:#DCDCDC;" |Ichthyosis vulgaris
|
|
|
|
Line 235: Line 235:
|
|
|-
|-
! Nummular Dermatitis
! align="center" style="background:#DCDCDC;" |Nummular Dermatitis
|
|
|
|
Line 264: Line 264:
|
|
|-
|-
|Netherton syndrome
! align="center" style="background:#DCDCDC;" |Netherton syndrome
|
|
|
|
Line 293: Line 293:
|
|
|-
|-
|Dubowitz syndrome
! align="center" style="background:#DCDCDC;" |Dubowitz syndrome
|
|
|
|
Line 322: Line 322:
|
|
|-
|-
|Erythrokeratodermia variabilis
! align="center" style="background:#DCDCDC;" |Erythrokeratodermia variabilis
|
|
|
|
Line 352: Line 352:
|-
|-
| rowspan="7" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Infection
| rowspan="7" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Infection
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Dermatophytes
! style="background: #DCDCDC; padding: 5px; text-align: center;" |Dermatophytes
|
|
|
|
Line 381: Line 381:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|-
|-
|Candida
! align="center" style="background:#DCDCDC;" |Candida
|
|
|
|
Line 410: Line 410:
|
|
|-
|-
|Herpes simplex
! align="center" style="background:#DCDCDC;" |Herpes simplex
|
|
|
|
Line 439: Line 439:
|
|
|-
|-
|Staphylococcus aureus
! align="center" style="background:#DCDCDC;" |Staphylococcus aureus
|
|
|
|
Line 468: Line 468:
|
|
|-
|-
|Molluscum Contagiosum
! align="center" style="background:#DCDCDC;" |Molluscum Contagiosum
|
|
|
|
Line 497: Line 497:
|
|
|-
|-
|'''Scabies'''
! align="center" style="background:#DCDCDC;" |Scabies
|
|
|
|
Line 526: Line 526:
|
|
|-
|-
|HIV
! align="center" style="background:#DCDCDC;" |HIV
|
|
|
|
Line 556: Line 556:
|-
|-
| rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Immunologic disorders
| rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Immunologic disorders
|Dermatitis herpetiformis
! align="center" style="background:#DCDCDC;" |Dermatitis herpetiformis
|
|
|
|
Line 585: Line 585:
|
|
|-
|-
|Pemphigus foliaceus
! align="center" style="background:#DCDCDC;" |Pemphigus foliaceus
|
|
|
|
Line 614: Line 614:
|
|
|-
|-
|Graft-versus-host disease
! align="center" style="background:#DCDCDC;" |Graft-versus-host disease
|
|
|
|
Line 643: Line 643:
|
|
|-
|-
|Dermatomyositis
! align="center" style="background:#DCDCDC;" |Dermatomyositis
|
|
|
|
Line 673: Line 673:
|-
|-
! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Immune deficiency
! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Immune deficiency
! style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Wiskott-Aldrich syndrome'''
! style="background: #DCDCDC; padding: 5px; text-align: center;" |Wiskott-Aldrich syndrome
|
|
|
|
Line 702: Line 702:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Hyper-IgE syndrome'''
! style="background: #DCDCDC; padding: 5px; text-align: center;" |Hyper-IgE syndrome
|
|
|
|
Line 731: Line 731:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|-
|-
|DiGeorge syndrome
! align="center" style="background:#DCDCDC;" |DiGeorge syndrome
|
|
|
|
Line 760: Line 760:
|
|
|-
|-
|Severe combined immunodeficiency (SCID)
! align="center" style="background:#DCDCDC;" |Severe combined immunodeficiency (SCID)
|
|
|
|
Line 789: Line 789:
|
|
|-
|-
|Ataxia telangiectasia
! align="center" style="background:#DCDCDC;" |Ataxia telangiectasia
|
|
|
|
Line 819: Line 819:
|-
|-
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Metabolic Diseases
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Metabolic Diseases
|Phenylketonuria
! align="center" style="background:#DCDCDC;" |Phenylketonuria
|
|
|
|
Line 848: Line 848:
|
|
|-
|-
|Tyrosinemia
! align="center" style="background:#DCDCDC;" |Tyrosinemia
|
|
|
|
Line 877: Line 877:
|
|
|-
|-
|Histidinemia
! align="center" style="background:#DCDCDC;" |Histidinemia
|
|
|
|
Line 906: Line 906:
|
|
|-
|-
|Multiple carboxylase deficiency
! align="center" style="background:#DCDCDC;" |Multiple carboxylase deficiency
|
|
|
|
Line 936: Line 936:
|-
|-
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Nutritional deficiencies
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Nutritional deficiencies
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Zinc deficiency'''
! style="background: #DCDCDC; padding: 5px; text-align: center;" |Zinc deficiency
|
|
|
|
Line 965: Line 965:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|-
|-
|Niacin (B3) deficiency
! align="center" style="background:#DCDCDC;" |Niacin (B3) deficiency
|
|
|
|
Line 994: Line 994:
|
|
|-
|-
|Pyridoxine (B6) deficiency
! align="center" style="background:#DCDCDC;" |Pyridoxine (B6) deficiency
|
|
|
|
Line 1,023: Line 1,023:
|
|
|-
|-
|Biotin (B7) deficiency
! align="center" style="background:#DCDCDC;" |Biotin (B7) deficiency
|
|
|
|
Line 1,053: Line 1,053:
|-
|-
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Malignancy
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Malignancy
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Mycosis fungoides'''
! style="background: #DCDCDC; padding: 5px; text-align: center;" |Mycosis fungoides
|
|
|
|
Line 1,082: Line 1,082:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|-
|-
|Histiocytosis X
! align="center" style="background:#DCDCDC;" |Histiocytosis X
|
|
|
|
Line 1,112: Line 1,112:
|-
|-
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Medications
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Medications
|Infliximab
! align="center" style="background:#DCDCDC;" |Infliximab
|
| align="center" style="background:#F5F5F5;" |  
|
| align="center" style="background:#F5F5F5;" |  
|
| align="center" style="background:#F5F5F5;" |  
|
| align="center" style="background:#F5F5F5;" |  
|
| align="center" style="background:#F5F5F5;" |  
|
| align="center" style="background:#F5F5F5;" |  
|
| align="center" style="background:#F5F5F5;" |  
|
| align="center" style="background:#F5F5F5;" |  
|
| align="center" style="background:#F5F5F5;" |  
|
| align="center" style="background:#F5F5F5;" |  
|
| align="center" style="background:#F5F5F5;" |  
|
| align="center" style="background:#F5F5F5;" |  
|
| align="center" style="background:#F5F5F5;" |  
|
| align="center" style="background:#F5F5F5;" |  
|
| align="center" style="background:#F5F5F5;" |  
|
| align="center" style="background:#F5F5F5;" |  
|
| align="center" style="background:#F5F5F5;" |  
|
| align="center" style="background:#F5F5F5;" |  
|
| align="center" style="background:#F5F5F5;" |  
|
| align="center" style="background:#F5F5F5;" |  
|
| align="center" style="background:#F5F5F5;" |  
|
| align="center" style="background:#F5F5F5;" |  
|
| align="center" style="background:#F5F5F5;" |  
|
| align="center" style="background:#F5F5F5;" |  
|
| align="center" style="background:#F5F5F5;" |  
|
| align="center" style="background:#F5F5F5;" |  
|
| align="center" style="background:#F5F5F5;" |  
|}
|}



Revision as of 16:25, 11 October 2018

Atopic dermatitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Atopic dermatitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography or Ultrasound

CT Scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Atopic dermatitis differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Atopic dermatitis differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Atopic dermatitis differential diagnosis

CDC on Atopic dermatitis differential diagnosis

Atopic dermatitis differential diagnosis in the news

Blogs onAtopic dermatitis differential diagnosis

Directions to Hospitals Treating Atopic dermatitis

Risk calculators and risk factors forAtopic dermatitis differential diagnosis

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.


Xyz Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Xyz from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Atopic dermatitis differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Atopic dermatitis differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Atopic dermatitis differential diagnosis

CDC on Atopic dermatitis differential diagnosis

Atopic dermatitis differential diagnosis in the news

Blogs on Atopic dermatitis differential diagnosis

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Atopic dermatitis differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

[Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as [differential dx1], [differential dx2], and [differential dx3].

Differentiating [Disease name] from other Diseases

    • Seborrhoeic dermatitis
      • onset during the 1st days or weeks of life, absence of pruritus, and presence of greasy scaling on a yellow-red base
      • Involvement of the top of the scalp (cradle cap), axilla, and diaper area makes it more likely the patient has seborrheic dermatitis, vs excoriated dermatitis involving the extensor surfaces, face, and trunk favour AE.
    • Sarcoptes scabiei
      • highly pruritic, erythematous papular lesions. In most cases, the typical burrows can be found on the flexor wrists, finger webs and genitalia. Similar symptoms in other family members
Category Diseases Etiology Inherited Acquired Demography History Clinical manifestations Para-clinical findings Gold standard Additional findings
Symptoms Physical examination
Lab Findings Imaging Histopathology
Appearance Itching Bleeding Fever BP Tenderness Nail pitting Other CBC ESR/CRP Electrolytes BUN/Cr LFT
Single/

Multiple

Rash Involved areas Pustule WBC Hb Plt
Skin disorders Allergic contact dermatitis
Irritant contact dermatitis
Seborrheic dermatitis
Psoriasis
Lichen simplex chronicus
Ichthyosis vulgaris
Nummular Dermatitis
Netherton syndrome
Dubowitz syndrome
Erythrokeratodermia variabilis
Infection Dermatophytes
Candida
Herpes simplex
Staphylococcus aureus
Molluscum Contagiosum
Scabies
HIV
Immunologic disorders Dermatitis herpetiformis
Pemphigus foliaceus
Graft-versus-host disease
Dermatomyositis
Immune deficiency Wiskott-Aldrich syndrome
Hyper-IgE syndrome
DiGeorge syndrome
Severe combined immunodeficiency (SCID)
Ataxia telangiectasia
Metabolic Diseases Phenylketonuria
Tyrosinemia
Histidinemia
Multiple carboxylase deficiency
Nutritional deficiencies Zinc deficiency
Niacin (B3) deficiency
Pyridoxine (B6) deficiency
Biotin (B7) deficiency
Malignancy Mycosis fungoides
Histiocytosis X
Medications Infliximab

References


Template:WikiDoc Sources